From Pharmaceutical to Biophysical Therapies: New Horizons in Inflammatory Bowel Disease Management
Important limitations exist in the current pharmacological landscape of Inflammatory Bowel Disease (IBD), such as variable response rates and treatment‐limiting adverse effects. In this review, we perform a critical assessment of the current literature on novel multimodal biophysical approaches showing alternative mechanisms of action to, and potential
Benedetta Ricchi +7 more
wiley +1 more source
Letter to the editor regarding to "autonomic recovery following submaximal exercise in yoga practitioners versus aerobic and strength-trained individuals". [PDF]
Sun Y.
europepmc +1 more source
Abstract Objectives Pediatric patients with chronic gastrointestinal (GI) conditions including inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS) on average endorse lower health related quality of life (HRQOL) than their healthy counterparts.
S. Taylor Younginer +6 more
wiley +1 more source
Heart rate variability as a dual-use digital biomarker: integrating clinical, AI, and operational perspectives on human performance and resilience. [PDF]
Burlacu A +4 more
europepmc +1 more source
Heart rate variability in cardiovascular disease diagnosis, prognosis and management. [PDF]
Wang BX +3 more
europepmc +1 more source
Pset, srednjovjekovna hrv. županija
Enciklopedijska natuknica o povijesti srednjovjekovne županije Pset.
openaire +1 more source
Hemodynamic instability and retinal vein occlusion in glaucoma: Comparative analysis of heart rate variability and choroidal perfusion. [PDF]
Lee JH, Park YH.
europepmc +1 more source
Weighing up risk factors for pneumonia: the role of mental illness and benzodiazepine use.
Brown, Jeremy Stuart, Quint, Jennifer K
core +1 more source
Understanding the shortcomings of heart rate variability as a tool for autonomic analysis. [PDF]
Banerjee A.
europepmc +1 more source
Effect of music intervention on heart rate variability: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Zhang E +10 more
europepmc +1 more source

